Author details

Full Name

Lloyd J Old

Affiliation

Ludwig Institute for Cancer Research

ORCID

Career Start Year

1959

Papers

754

H Index

152

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35664317	Systems-Level Mapping of Cancer Testis Antigen 1b/a to Sarcoma Pathways Identifies Activated Ran Binding-2 E3 SUMO-Protein Ligase and Transducin-Like Enhancer Protein 1.	Front Genet	2022
32317292	Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma.	J Immunother Cancer	2020
30038035	Pillars Article: IFNÎ³ and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity. <i>Nature</i>. 2001. 410: 1107-1111.	J Immunol	2018
25081390	NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.	Int J Cancer	2015
26447332	Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses.	Sci Rep	2015
26194713	PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer.	Eur J Nucl Med Mol Imaging	2015
24764581	Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells.	Cancer Immunol Res	2014
22864522	Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma.	Invest New Drugs	2013
24045055	Process development and production of cGMP grade Melan-A for cancer vaccine clinical trials.	Protein Expr Purif	2013
24081977	Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein.	Clin Cancer Res	2013
24195083	The human cell surfaceome of breast tumors.	Biomed Res Int	2013
23882157	NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma.	Cancer Immun	2013
23936189	Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer.	PLoS One	2013
23390374	A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy.	Cancer Immun	2013
23436617	Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes.	Eur J Immunol	2013
23554566	A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.	Sarcoma	2013
23348793	Imaging of tumor vascularization using fluorescence molecular tomography to monitor arginine deiminase treatment in melanoma.	Mol Imaging	2013
21413013	Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.	Int J Cancer	2012
23390371	MAGE-A3 is highly expressed in a subset of colorectal cancer patients.	Cancer Immun	2012
23390370	SurfaceomeDB: a cancer-orientated database for genes encoding cell surface proteins.	Cancer Immun	2012
23032745	Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients.	Clin Cancer Res	2012
22684412	A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylation.	Int J Oncol	2012
22847809	Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity.	Clin Cancer Res	2012
22840835	T cell assays and MIATA: the essential minimum for maximum impact.	Immunity	2012
22923163	KP-CoT-23 (CCDC83) is a novel immunogenic cancer/testis antigen in colon cancer.	Int J Oncol	2012
22437872	Antibody therapy of cancer.	Nat Rev Cancer	2012
22454499	Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients.	Proc Natl Acad Sci U S A	2012
22318866	Intracellular tumor-associated antigens represent effective targets for passive immunotherapy.	Cancer Res	2012
22318521	Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.	Nature	2012
22228793	Novel mechanistic insights into arginine deiminase pharmacology suggest 18F-FDG is not suitable to evaluate clinical response in melanoma.	J Nucl Med	2012
22323448	Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma.	Blood	2012
22427632	Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells.	J Immunol	2012
22109656	Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.	Int J Cancer	2012
22134507	Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase.	Br J Cancer	2012
21547902	Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues.	Int J Cancer	2012
20346054	Effect of tyrosine kinase inhibitor treatment of renal cell carcinoma on the accumulation of carbonic anhydrase IX-specific chimeric monoclonal antibody cG250.	BJU Int	2011
22016418	Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma.	Hum Reprod	2011
22068895	124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET.	J Nucl Med	2011
22114198	Trypanosoma cruzi as an effective cancer antigen delivery vector.	Proc Natl Acad Sci U S A	2011
22168571	Defining the critical hurdles in cancer immunotherapy.	J Transl Med	2011
21858191	Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors.	PLoS One	2011
21764796	(124)I-huA33 antibody PET of colorectal cancer.	J Nucl Med	2011
21933959	Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.	Proc Natl Acad Sci U S A	2011
21565982	MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin.	Clin Cancer Res	2011
21754986	MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer.	PLoS One	2011
21698545	Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIXâ¿¢.	Cancer Immunol Immunother	2011
21318630	Expression of the human cancer/testis antigen NY-SAR-35 is activated by CpG island hypomethylation.	Biotechnol Lett	2011
21315712	Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX.	Eur J Pharmacol	2011
21365782	Expression and purification of cGMP grade NY-ESO-1 for clinical trials.	Biotechnol Prog	2011
21305280	A proteomic analysis of the Pichia pastoris secretome in methanol-induced cultures.	Appl Microbiol Biotechnol	2011

1 - 50 of 754

Zhiya Yu

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1995

Number of shared co-authors 2

Veena Kapoor

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1991

Number of shared co-authors 1

Roger Chammas

Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo

Career Start Year 1989

Number of shared co-authors 8

Paul E Steele

Cincinnati Children's Hospital

Career Start Year 1989

Number of shared co-authors 0

Satyajit Ray

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1986

Number of shared co-authors 1

Nicholas P Restifo

National Cancer Institute, National Institutes of Health (NIH)

Career Start Year 1985

Number of shared co-authors 5

Seth M Steinberg

Center for Cancer Research, National Cancer Institute

Career Start Year 1984

Number of shared co-authors 4

Giorgio Inghirami

Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital

Career Start Year 1984

Number of shared co-authors 2

Stefan Burdach

Technische Universitat Munchen

Career Start Year 1981

Number of shared co-authors 2

Robert E Lewis

University of Nebraska Medical Center

Career Start Year 1980

Number of shared co-authors 0

Brian Seed

Center for Computational and Integrative Biology, Massachusetts General Hospital

Career Start Year 1980

Number of shared co-authors 2

Fabien Calvo

Universite de Paris-Cite

Career Start Year 1979

Number of shared co-authors 1

Peter S Linsley

8Benaroya Research Institute

Career Start Year 1978

Number of shared co-authors 2

Timothy L Ratliff

Purdue University

Career Start Year 1978

Number of shared co-authors 0

Carl A K Borrebaeck

Lund University

Career Start Year 1977

Number of shared co-authors 1

Victor H Engelhard

University of Virginia School of Medicine

Career Start Year 1976

Number of shared co-authors 1

Wolfgang E Berdel

University Hospital Munster

Career Start Year 1976

Number of shared co-authors 0

Jerome Ritz

Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital

Career Start Year 1976

Number of shared co-authors 2

William E Grizzle

University of Alabama at Birmingham

Career Start Year 1974

Number of shared co-authors 0

Owen N Witte

University of California los angeles

Career Start Year 1972

Number of shared co-authors 4

Ellen R Richie

The University of Texas MD Anderson Cancer Center

Career Start Year 1970

Number of shared co-authors 0

George Yancey Gillespie

Heersink School of Medicine, The University of Alabama at Birmingham

Career Start Year 1970

Number of shared co-authors 1

Tak W Mak

Princess Margaret Cancer Centre, University Health Network

Career Start Year 1970

Number of shared co-authors 3

John N Weinstein

The University of Texas MD Anderson Cancer Center

Career Start Year 1968

Number of shared co-authors 10

Charles J Sherr

St. Jude Children's Research Hospital

Career Start Year 1968

Number of shared co-authors 0

William A Robinson

National Centre for Asbestos Related Diseases, University of Western Australia

Career Start Year 1967

Number of shared co-authors 4

David W Scott

University of British Columbia

Career Start Year 1965

Number of shared co-authors 0

John R Wunderlich

National Cancer Institute

Career Start Year 1963

Number of shared co-authors 1

Steven A Rosenberg

University of Colorado School of Medicine

Career Start Year 1961

Number of shared co-authors 6

Anthony P Monaco

Monash University

Career Start Year 1958

Number of shared co-authors 0

row(s) 1 - 30 of 30

Yao-Tseng Chen

From Population Health Services (Chen)

Co-authored papers 120

Sacha Gnjatic

The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Co-authored papers 84

Andrew J G Simpson

University of Hull

Co-authored papers 27

Yuichi Obata

RIKEN BioResource Research Center

Co-authored papers 22

Chaitanya Divgi

Columbia University Medical Center Kreitchman PET Center

Co-authored papers 21

Jonathan Cebon

Australia Olivia Newton-John Cancer Research Institute, La Trobe University

Co-authored papers 19

Nasser K Altorki

New York-Presbyterian Hospital

Co-authored papers 17

Otavia L Caballero

Ludwig Institute for Cancer Research Ltd.

Co-authored papers 16

Edouard C Nice

Monash University

Co-authored papers 14

Francisco X Real

Spanish National Cancer Research Centre-CNIO

Co-authored papers 13

Terrance G Johns

Telethon Kids Institute

Co-authored papers 13

Feng Qian

Co-authored papers 11

William D Hardy

Co-authored papers 11

John L Humm

Memorial Sloan Kettering Cancer Center

Co-authored papers 9

Martin W Brechbiel

National Institutes of Health

Co-authored papers 8

Carmel Murone

Olivia Newton-John Cancer Research Institute

Co-authored papers 8

Neeta Pandit-Taskar

Memorial Sloan Kettering Cancer Center

Co-authored papers 8

Victor E Reuter

Memorial Sloan Kettering Cancer Center

Co-authored papers 8

Anthony T Papenfuss

Co-authored papers 7

Paulette Mhawech-Fauceglia

University of Southern California

Co-authored papers 7

Webster K Cavenee

Ludwig Institute for Cancer Research, University of California San Diego

Co-authored papers 6

Ettore Appella

Co-authored papers 6

Ira Mellman

Genentech Inc.

Co-authored papers 5

Richard J Simpson

Co-authored papers 5

Shimon Sakaguchi

Institute for Frontier Medical Sciences, Kyoto University

Co-authored papers 5

Robert L Moritz

Institute for Systems Biology

Co-authored papers 5

Holger Moch

University Hospital Zurich

Co-authored papers 5

Yves Fradet

CHU de Quebec-Universite Laval

Co-authored papers 4

Gavin P Dunn

Washington University School of Medicine

Co-authored papers 4

Katherine S Panageas

Memorial Sloan Kettering Cancer Center

Co-authored papers 4

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators